Platinum Investment Management’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
BI
LCM
OCA
ACM
SCM
Platinum Investment Management's PVLA Position: Q2 2023 in Review
Platinum Investment Management sold out of Palvella Therapeutics (PVLA) in Q2 2023, closing a stake of 12,188 shares — an estimated $952K sold.
Platinum Investment Management first reported a position in PVLA in Q1 2018 and held it in 21 quarters. The position peaked at $5.32M in Q3 2021. 49 funds tracked by Wall St. Rank hold PVLA as of Q2 2023.
- Platinum Investment Management reported no remaining Palvella Therapeutics position as of Q2 2023 after selling out during the quarter.
- Platinum Investment Management sold 12,188 Palvella Therapeutics shares in Q2 2023, an estimated $952K.
- Platinum Investment Management first reported a position in Palvella Therapeutics in Q1 2018 and held it in 21 quarters.
- Platinum Investment Management's Palvella Therapeutics position peaked at $5.32M in Q3 2021.
- 49 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2023.
Based on Platinum Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.